Macquarie Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Macquarie Group’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,547,957	Closed	-$60.9M	–	2593
2021 Q1	$60.9M	Sell	2,547,957 -678,388	-21%	-$12.6M	0.09%	289
2020 Q4	$47.1M	Buy	3,226,345 +539,348	+20%	+$7.15M	0.07%	327
2020 Q3	$38.2M	Buy	2,686,997 +1,368,565	+104%	+$20.9M	0.06%	325
2020 Q2	$19.4M	Buy	+1,318,432	New	+$13.4M	0.03%	469

Macquarie Group's GNMK Position: Q2 2021 in Review

Macquarie Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 2,547,957 shares — an estimated $60.9M sold.

Macquarie Group first reported a position in GNMK in Q2 2020 and held it in 4 quarters. The position peaked at $60.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Macquarie Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Macquarie Group sold 2,547,957 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $60.9M.
Macquarie Group first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 4 quarters.
Macquarie Group's GenMark Diagnostics, Inc position peaked at $60.9M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Macquarie Group's 13F filing for Q2 2021, filed 13 Aug 2021.